Medicare Access to Radiology Care Act of 2026
Summary
The Medicare Access to Radiology Care Act of 2026 was introduced in the Senate on May 21, 2026, and referred to the Committee on Finance. It proposes to authorize Medicare payment for services provided by radiologist assistants under radiologist supervision, but no specific funding is authorized and the bill is in its earliest legislative stage with only one cosponsor. No identifiable near-term market impact for publicly traded companies.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Bill is in earliest stage — introduced and referred to committee with minimal cosponsorship.
- 2.No funding amount authorized; any future Medicare payment rates would be set by rulemaking.
- 3.No publicly traded company has a direct, material revenue exposure to this legislation at this time.
Market Implications
No material market implications at this stage. If the bill progresses, radiology staffing firms and hospital operators could see minor operational benefits, but any effect would be years away and contingent on subsequent rulemaking and appropriations.
Full Analysis
The bill was introduced by Sen. Boozman (R-AR) with one cosponsor, Sen. Lujan, on May 21, 2026, and read twice before being referred to the Committee on Finance. At this stage, the bill has not been reported out of committee, has no companion bill in the House, and no further action has been taken. The bill text defines 'radiologist assistant services' and would amend the Social Security Act to include these services under Medicare Part B coverage. However, the bill does not authorize any specific dollar amount for payments; it simply creates a coverage pathway. Actual payment rates would be determined through Medicare rulemaking after passage, and no appropriations are included. The legislative process is at the very beginning, with only two actions in the record, both on the same day. The narrow scope — affecting only Medicare coverage for a single provider type — limits potential market impact. No publicly traded company's revenue is directly and measurably tied to this bill's passage. Affected companies would be those employing radiologist assistants, such as radiology practice management firms or hospital chains, but the link is too indirect for confident inclusion. No real market data is available to analyze price trends. Remaining steps include committee markup, floor consideration, House passage of a companion bill, conference committee if needed, and final passage — a multi-year path, if it moves at all.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.